Samil Pharm (000520) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.016x

Based on the latest financial reports, Samil Pharm (000520) has a cash flow conversion efficiency ratio of 0.016x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.44 Billion ≈ $1.66 Million USD) by net assets (₩149.26 Billion ≈ $101.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Samil Pharm (000520) net asset quality to measure how much of total assets are equity-financed.

Samil Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Samil Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Samil Pharm (000520) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Samil Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samil Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Marks and Spencer Group PLC LSE:MKS	0.289x
KB Star REIT Co. Ltd. KO:432320	0.005x
Yuen Chang Stainless Steel Co Ltd TW:2069	0.062x
Oncoclinicas do Brasil SA:ONCO3	0.127x
Leadtrend Technology Corp TW:3588	0.004x
Rockridge Resources Ltd V:ROCK	-0.026x
Pudumjee Paper Products Limited NSE:PDMJEPAPER	0.084x
Alpha Astika Akinita S.A AT:ASTAK	-0.330x

Annual Cash Flow Conversion Efficiency for Samil Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samil Pharm from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Samil Pharm (000520) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.12 Billion ≈ $119.36 Million	₩2.59 Billion ≈ $1.76 Million	0.015x	-84.00%
2023-12-31	₩127.83 Billion ≈ $86.63 Million	₩11.75 Billion ≈ $7.96 Million	0.092x	+178.32%
2022-12-31	₩125.82 Billion ≈ $85.27 Million	₩4.15 Billion ≈ $2.82 Million	0.033x	+53.20%
2021-12-31	₩65.75 Billion ≈ $44.56 Million	₩1.42 Billion ≈ $960.19K	0.022x	-82.38%
2020-12-31	₩63.55 Billion ≈ $43.07 Million	₩7.77 Billion ≈ $5.27 Million	0.122x	-28.06%
2019-12-31	₩62.27 Billion ≈ $42.20 Million	₩10.59 Billion ≈ $7.18 Million	0.170x	+463.81%
2018-12-31	₩56.08 Billion ≈ $38.01 Million	₩-2.62 Billion ≈ $-1.78 Million	-0.047x	-163.08%
2017-12-31	₩51.17 Billion ≈ $34.68 Million	₩3.79 Billion ≈ $2.57 Million	0.074x	-30.47%
2016-12-31	₩52.87 Billion ≈ $35.83 Million	₩5.63 Billion ≈ $3.82 Million	0.107x	+98.58%
2015-12-31	₩54.41 Billion ≈ $36.87 Million	₩2.92 Billion ≈ $1.98 Million	0.054x	+124.94%
2014-12-31	₩55.42 Billion ≈ $37.55 Million	₩-11.92 Billion ≈ $-8.08 Million	-0.215x	-277.61%
2013-12-31	₩70.03 Billion ≈ $47.46 Million	₩-3.99 Billion ≈ $-2.70 Million	-0.057x	-171.32%
2012-12-31	₩62.87 Billion ≈ $42.61 Million	₩5.02 Billion ≈ $3.40 Million	0.080x	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$101.57 Million

₩149.88 Billion KRW

Market Cap Rank

#19145 Global

#922 in Korea

Share Price

₩7060.00

Change (1 day)

+0.71%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13